innovative platform technology

Innovative Technology Platform

Entera's innovative technology enables oral drug delivery of large molecules

27163516 pills

Pipeline of Drug Development

Entera conducts clinical trials of three oral drugs based on a proven active compound

27163516 brain green

Experienced Management Team

The managers of Entera have more than 50 years of experience in drug development

October 31, 2013 – Additional analysis of Entera's successfully completed Phase I clinical trial using oral PTH 1-34 show that a significant reduction in blood calcium levels was also attained. This provides additional support to the applicability of Entera’s oral PTH 1-34 in the treatment of hypoparathyroidism.